Psoriasis News and Research

Latest Psoriasis News and Research

Biogen Idec files rFIXFc BLA with FDA for treatment of hemophilia B

Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.

7 Jan 2013

Racial disparities in hospital care of US children

The US healthcare system needs to undergo further reform if racial disparities in pediatric surgical care are to be addressed, report researchers.

3 Jan 2013

Pediatric caustic ingestion injuries ‘much lower than believed’

The public health burden associated with children swallowing caustic chemicals is less than widely believed, US researchers report in the Archives of Otolaryngology - Head and Neck Surgery.

2 Jan 2013

Rhinosinusitis without nasal polyps ‘predisposes to psoriasis’

People who suffer from chronic rhinosinusitis without nasal polyps have around twice the risk for psoriasis as the general population, a Taiwanese study has found.

28 Dec 2012

More children surviving heart attacks in hospital

Approximately three times more children survived in-hospital cardiac arrest in 2009 compared with 2000, indicate data from the Get With The Guidelines–Resuscitation registry.

24 Dec 2012

Continuous vancomycin optimizes neonate therapy

Researchers recommend that a patient-tailored dosing regimen is used routinely in neonates for continuous infusion therapy of the antibiotic, vancomycin.

24 Dec 2012

Extended steroid treatment fails to reduce pediatric nephrotic relapse

Study findings indicate that extending initial prednisolone treatment durations in patients with pediatric nephrotic syndrome from 3 to 6 months without increasing the overall dose does not reduce the number of relapses.

22 Dec 2012

French method successful for clubfoot

Researchers have demonstrated the efficacy of the “French” functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.

20 Dec 2012

Positive top-line results from Idera’s IMO-3100 Phase 2a trial on plaque psoriasis

Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.

20 Dec 2012

Researchers reveal role of dendritic cells in Type 1 diabetes

The researchers reveal the role of the innate immune cells, especially the dendritic cells, that cause the activation of the killer T-lymphocytes whose action is directed against the p pancreatic cells. The results obtained in mice make it possible to consider new ways of regulating the auto-immune reaction generated by the innate immune cells.

20 Dec 2012

Umbilical cord stem cell therapy shows promise in infant BPD

Researchers have successfully used human umbilical cord stem cells to partially prevent damage and restore lung structure and function in an experimental animal model of bronchopulmonary dysplasia.

19 Dec 2012

Amgen expected to enter a guilty plea to unspecified charges

The biotech giant is expected to plead guilty in a New York federal court criminal case. Some reports suggest the charges relate to "misbranding" -- which refers to the promotion of drugs for uses that have not gained the Food and Drug Administration's approval.

19 Dec 2012

Ceramic-on-ceramic hips good option for juvenile arthritis

Study results suggest that ceramic-on-ceramic artificial hip joints offer a better medium-term prognosis than metal- or ceramic-on-polyethylene joints for children with juvenile idiopathic arthritis.

18 Dec 2012

Mother–infant pairs admitted to ICU have poor outcomes

Mother–baby pairs with co-admission to intensive care units after delivery are more likely to experience separation due to interfacility transfer, and have higher mortality rates, than pairs in which either mothers or babies are admitted, show study results.

17 Dec 2012